Indonesian Political, Business & Finance News

Weakening Rupiah Threatens to Raise Domestic Medicine Prices

| | Source: Media Indonesia Translated from Indonesian | Economy
Weakening Rupiah Threatens to Raise Domestic Medicine Prices
Image: Media Indonesia

The Chairman of the Trade and Raw Material Industry Committee of GP Farmasi, Vincent Harijanto, stated that medicine prices in Indonesia have not yet increased despite fluctuations in the Rupiah against the US Dollar and rising oil prices. However, Indonesia still imports between 80 and 90 per cent of its domestic pharmaceutical raw material requirements.

“There has been no increase yet as we still have stocks available to distribute to all retailers, including hospitals and pharmacies,” Vincent said on Wednesday.

He could not guarantee that medicine prices would remain stagnant due to unavoidable factors such as the rising costs of plastic and raw materials. “We are not arbitrary in our internal discussions within the pharmaceutical industry; we do not raise prices without reason. However, there are unavoidable elements. Beyond raw materials, even the cost of plastic is rising, and medicine must be packaged,” he added.

He further noted that if the current trend continues, the industry will face significant difficulties without government assistance, given that approximately 90 per cent of raw materials are imported. Vincent emphasised that while the pharmaceutical industry is aware of the potential for price hikes, GP Farmasi is doing its best to maintain price stability.

“However, once our stocks are depleted and we are forced to purchase at higher prices, that is something GP Farmasi will likely have to address,” he revealed.

Previously, the Minister of Health, Budi Gunadi Sadito, ensured that medicine prices for the National Health Insurance (JKN) programme would remain controlled and are not expected to rise. “We have reviewed which price increases are reasonable and which are not. For BPJS medicines, we have managed to maintain stability,” said the Minister.

He explained that the rise in the US Dollar exchange rate does not automatically result in a proportional increase in medicine prices, as most domestic production cost components are still denominated in Rupiah. Consequently, the government has calculated a reasonable limit for price increases. An increase in the range of 10 to 20 per cent is considered reasonable, whereas anything above that is viewed as an attempt at unilateral profiteering.

“Ten to 20 per cent is still reasonable. But if it exceeds that, do not use it as an opportunity to take excessive profits,” the Minister concluded.

More from 17 June 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/weakening-rupiah-threatens-to-raise-domestic-medicine-prices-1781675442)
Originally published by Media Indonesia (https://mediaindonesia.com/humaniora/901348/dampak-rupiah-melemah-harga-obat-dalam-negeri-terancam-naik), translated from Indonesian
Print